Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
49 studies found for:    " January 30, 2008":" February 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Lopinavir/Ritonavir Monotherapy in Children
Condition: HIV Infections
Intervention: Drug: LPV/r
22 Completed
Has Results
A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.
Condition: HIV Infections
Interventions: Drug: ritonavir;   Drug: saquinavir [Invirase]
23 Completed Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
Condition: HIV Infections
Intervention: Biological: MVA-mBN120B
24 Completed Pharmacokinetics of Low Dose Ritonavir
Condition: HIV Infections
Intervention: Drug: ritonavir and saquinavir
25 Withdrawn Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®
Condition: HIV Infections
Intervention: Drug: generic GPO saquinavir and novir vs invirase and norvir
26 Completed Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women
Condition: HIV Infections
Intervention: Drug: generic lopinavir/ritonavir
27 Completed Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
Condition: HIV Infections
Intervention: Behavioral: NO BI Drug administered
28 Completed
Has Results
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
29 Completed INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV therapy
30 Completed Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
Condition: HIV Infections
Intervention: Drug: TPV
31 Completed Acupuncture for Nausea in HIV
Condition: HIV Infections
Interventions: Other: Acupuncture;   Other: Individualized Acup based on TCM diagnosis;   Other: Sham Acup
32 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
33 Withdrawn Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
34 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
35 Terminated
Has Results
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
36 Completed
Has Results
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
Conditions: HIV Infections;   Hyperlipidemia
Interventions: Drug: Pravastatin;   Drug: Darunavir;   Drug: Ritonavir;   Other: Washout
37 Unknown  Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
38 Active, not recruiting Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions: HIV Infections;   Staphylococcal Infections
Interventions: Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: Placebo
39 Completed Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine
40 Completed
Has Results
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Condition: HIV Infection
Intervention: Drug: Tenofovir + emtricitabine + raltegravir.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.